186 related articles for article (PubMed ID: 19933214)
1. TCDD and a putative endogenous AhR ligand, ITE, elicit the same immediate changes in gene expression in mouse lung fibroblasts.
Henry EC; Welle SL; Gasiewicz TA
Toxicol Sci; 2010 Mar; 114(1):90-100. PubMed ID: 19933214
[TBL] [Abstract][Full Text] [Related]
2. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
Forrester AR; Elias MS; Woodward EL; Graham M; Williams FM; Reynolds NJ
J Dermatol Sci; 2014 Jan; 73(1):10-22. PubMed ID: 24161567
[TBL] [Abstract][Full Text] [Related]
3. A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo.
Henry EC; Bemis JC; Henry O; Kende AS; Gasiewicz TA
Arch Biochem Biophys; 2006 Jun; 450(1):67-77. PubMed ID: 16545771
[TBL] [Abstract][Full Text] [Related]
4. ITE and TCDD differentially regulate the vascular remodeling of rat placenta via the activation of AhR.
Wu Y; Chen X; Zhou Q; He Q; Kang J; Zheng J; Wang K; Duan T
PLoS One; 2014; 9(1):e86549. PubMed ID: 24475139
[TBL] [Abstract][Full Text] [Related]
5. Targeted deletion of the aryl hydrocarbon receptor in dendritic cells prevents thymic atrophy in response to dioxin.
Beamer CA; Kreitinger JM; Cole SL; Shepherd DM
Arch Toxicol; 2019 Feb; 93(2):355-368. PubMed ID: 30499018
[TBL] [Abstract][Full Text] [Related]
6. ITE, an endogenous aryl hydrocarbon receptor ligand, suppresses endometrial cancer cell proliferation and migration.
Bian Y; Li Y; Shrestha G; Wen X; Cai B; Wang K; Wan X
Toxicology; 2019 Jun; 421():1-8. PubMed ID: 30953668
[TBL] [Abstract][Full Text] [Related]
7. Binding Mode and Structure-Activity Relationships of ITE as an Aryl Hydrocarbon Receptor (AhR) Agonist.
Dolciami D; Gargaro M; Cerra B; Scalisi G; Bagnoli L; Servillo G; Fazia MAD; Puccetti P; Quintana FJ; Fallarino F; Macchiarulo A
ChemMedChem; 2018 Feb; 13(3):270-279. PubMed ID: 29266750
[TBL] [Abstract][Full Text] [Related]
8. Activation of Aryl Hydrocarbon Receptor by ITE Improves Cardiac Function in Mice After Myocardial Infarction.
Seong E; Lee JH; Lim S; Park EH; Kim E; Kim CW; Lee E; Oh GC; Choo EH; Hwang BH; Kim CJ; Ihm SH; Youn HJ; Chung WS; Chang K
J Am Heart Assoc; 2021 Jul; 10(13):e020502. PubMed ID: 34157850
[TBL] [Abstract][Full Text] [Related]
9. An endogenous aryl hydrocarbon receptor ligand enhances de novo generation of regulatory T cells in humans.
Zamali I; Rekik R; Belhadj Hmida N; Ben Hmid A; Kammoun O; Barbouche MR; Ben Ahmed M
J Leukoc Biol; 2019 Feb; 105(2):291-295. PubMed ID: 30500079
[TBL] [Abstract][Full Text] [Related]
10. The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiation.
Lehmann GM; Xi X; Kulkarni AA; Olsen KC; Pollock SJ; Baglole CJ; Gupta S; Casey AE; Huxlin KR; Sime PJ; Feldon SE; Phipps RP
Am J Pathol; 2011 Apr; 178(4):1556-67. PubMed ID: 21406171
[TBL] [Abstract][Full Text] [Related]
11. Effects of AhR ligands on the production of immunoglobulins in purified mouse B cells.
Yoshida T; Katsuya K; Oka T; Koizumi S; Wakita D; Kitamura H; Nishimura T
Biomed Res; 2012 Apr; 33(2):67-74. PubMed ID: 22572380
[TBL] [Abstract][Full Text] [Related]
12. The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug-resistance in hepatocellular carcinoma.
Zhang X; He B; Chen E; Lu J; Wang J; Cao H; Li L
J Cell Physiol; 2021 Jan; 236(1):178-192. PubMed ID: 32510618
[TBL] [Abstract][Full Text] [Related]
13. ITE Suppresses Angiogenic Responses in Human Artery and Vein Endothelial Cells: Differential Roles of AhR.
Li Y; Wang K; Zou QY; Jiang YZ; Zhou C; Zheng J
Reprod Toxicol; 2017 Dec; 74():181-188. PubMed ID: 28986273
[TBL] [Abstract][Full Text] [Related]
14. Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice.
Yan J; Tung HC; Li S; Niu Y; Garbacz WG; Lu P; Bi Y; Li Y; He J; Xu M; Ren S; Monga SP; Schwabe RF; Yang D; Xie W
Gastroenterology; 2019 Sep; 157(3):793-806.e14. PubMed ID: 31170413
[TBL] [Abstract][Full Text] [Related]
15. Adaptive changes in global gene expression profile of lung carcinoma A549 cells acutely exposed to distinct types of AhR ligands.
Procházková J; Strapáčová S; Svržková L; Andrysík Z; Hýžďalová M; Hrubá E; Pěnčíková K; Líbalová H; Topinka J; Kléma J; Espinosa JM; Vondráček J; Machala M
Toxicol Lett; 2018 Aug; 292():162-174. PubMed ID: 29704546
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Aryl Hydrocarbon Receptor with Microbial Metabolite Mimics Alleviates Experimental Colitis in Mice.
Grycová A; Joo H; Maier V; Illés P; Vyhlídalová B; Poulíková K; Sládeková L; Nádvorník P; Vrzal R; Zemánková L; Pečinková P; Poruba M; Zapletalová I; Večeřa R; Anzenbacher P; Ehrmann J; Ondra P; Jung JW; Mani S; Dvořák Z
J Med Chem; 2022 May; 65(9):6859-6868. PubMed ID: 35416668
[TBL] [Abstract][Full Text] [Related]
17. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis.
Quintana FJ; Murugaiyan G; Farez MF; Mitsdoerffer M; Tukpah AM; Burns EJ; Weiner HL
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20768-73. PubMed ID: 21068375
[TBL] [Abstract][Full Text] [Related]
18. Consequences of AhR activation in steady-state dendritic cells.
Simones T; Shepherd DM
Toxicol Sci; 2011 Feb; 119(2):293-307. PubMed ID: 21097750
[TBL] [Abstract][Full Text] [Related]
19. ITE inhibits growth of human pulmonary artery endothelial cells.
Pang LP; Li Y; Zou QY; Zhou C; Lei W; Zheng J; Huang SA
Exp Lung Res; 2017 Oct; 43(8):283-292. PubMed ID: 29140133
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor-ligand axis mediates pulmonary fibroblast migration and differentiation through increased arachidonic acid metabolism.
Su HH; Lin HT; Suen JL; Sheu CC; Yokoyama KK; Huang SK; Cheng CM
Toxicology; 2016 Aug; 370():116-126. PubMed ID: 27697457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
